BOSTON SCIENTIFIC CORP is 63.7x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($71.33 B vs $1.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KMTS | BSX |
|---|---|---|
| Market cap | $1.12 B | $71.33 B |
| US-listed rank | #2558 | #239 |
| Revenue (latest FY) | $59.81M | $20.07B |
| Net income (latest FY) | -$113.81M | - |
| Net margin | -190.3% | - |
| SEC filings | 105 | 1,009 |
BOSTON SCIENTIFIC CORP is 63.7x more valuable than KESTRA MEDICAL TECHNOLOGIES, LTD. by market capitalization ($71.33 B vs $1.12 B).
In their latest fiscal years, KESTRA MEDICAL TECHNOLOGIES, LTD. reported $59.81M in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: KESTRA MEDICAL TECHNOLOGIES, LTD. and BOSTON SCIENTIFIC CORP, or browse the full rankings.